Risk factors for progression to castration-resistant prostate cancer in metastatic prostate cancer patients

Purpose: To investigate the risk factors for progression to castration-resistant prostate cancer (CRPC) in metastatic prostate cancer (mPCa) patients who underwent androgen deprivation therapy (ADT). Methods: We analyzed 216 patients with mPCa who underwent ADT between January 2006 and December 2015...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ting-Ting, Chen, Ye-Hui, Wu, Yu-Peng, Chen, Shao-Zhan, Li, Xiao-Dong, Lin, Yun-Zhi, Chen, Shao-Hao, Zheng, Qing-Shui, Wei, Yong, Xu, Ning, Xue, Xue-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775699/
https://www.ncbi.nlm.nih.gov/pubmed/31632505
http://dx.doi.org/10.7150/jca.30731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775699/
https://www.ncbi.nlm.nih.gov/pubmed/31632505
http://dx.doi.org/10.7150/jca.30731

Ejemplares similares